{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:44:44Z","timestamp":1775587484130,"version":"3.50.1"},"publisher-location":"Cham","reference-count":38,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319073194","type":"print"},{"value":"9783319073200","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-07320-0_3","type":"book-chapter","created":{"date-parts":[[2014,7,19]],"date-time":"2014-07-19T05:19:41Z","timestamp":1405747181000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High Density Lipoproteins and Ischemia Reperfusion Injury: The Therapeutic Potential of HDL to Modulate Cell Survival Pathways"],"prefix":"10.1007","author":[{"given":"Richard W.","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/00041433-199604000-00006","volume":"7","author":"PJ Barter","year":"1996","unstructured":"Barter PJ, Rye KA. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol. 1996;7:82\u20137.","journal-title":"Curr Opin Lipidol"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","volume":"367","author":"GG Schwartz","year":"2012","unstructured":"Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012;367:2089\u201399.","journal-title":"N Engl J Med"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00041433-200406000-00006","volume":"15","author":"L Rohrer","year":"2004","unstructured":"Rohrer L, Hersberger M, von Eckardstein A. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol. 2004;15:269\u201378.","journal-title":"Curr Opin Lipidol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1253\/circj.CJ-13-1025","volume":"77","author":"W Annema","year":"2013","unstructured":"Annema W, von Eckardstein A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J. 2013;77:2432\u201348.","journal-title":"Circ J"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1194\/jlr.R035725","volume":"54","author":"AS Shah","year":"2013","unstructured":"Shah AS, Tan L, Long JL, Davidson WS. Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J Lipid Res. 2013;54:2575\u201385.","journal-title":"J Lipid Res"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1194\/jlr.R036095","volume":"54","author":"A Kontush","year":"2013","unstructured":"Kontush A, Lhomme M, Chapman MJ. Unraveling the complexities of the HDL lipidome. J Lipid Res. 2013;54:2950\u201363.","journal-title":"J Lipid Res"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2337\/db11-1221","volume":"61","author":"J Petremand","year":"2012","unstructured":"Petremand J, Puyal J, Chatton JY, Duprez J, Allagnat F, Frias M, et al. HDLs protect pancreatic beta-cells against ER stress by restoring protein folding and trafficking. Diabetes. 2012;61:1100\u201311.","journal-title":"Diabetes"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1161\/CIRCULATIONAHA.113.001551","volume":"128","author":"M Lehti","year":"2013","unstructured":"Lehti M, Donelan E, Abplanalp W, Al-Massadi O, Habegger KM, Weber J, et al. High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice. Circulation. 2013;128:2364\u201371.","journal-title":"Circulation"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/bjo.2005.085076","volume":"90","author":"BY Ishida","year":"2006","unstructured":"Ishida BY, Duncan KG, Bailey KR, Kane JP, Schwartz DM. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br J Ophthalmol. 2006;90:616\u201320.","journal-title":"Br J Ophthalmol"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0076-6879(96)63004-3","volume":"263","author":"P Alaupovic","year":"1996","unstructured":"Alaupovic P. Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins. Methods Enzymol. 1996;263:32\u201360.","journal-title":"Methods Enzymol"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cvr\/cvp070","volume":"82","author":"K Sattler","year":"2009","unstructured":"Sattler K, Levkau B. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc Res. 2009;82:201\u201311.","journal-title":"Cardiovasc Res"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1160\/TH08-11-0734","volume":"101","author":"DJ Hausenloy","year":"2009","unstructured":"Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost. 2009;101:626\u201334.","journal-title":"Thromb Haemost"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2008.10.029","volume":"204","author":"DJ Hausenloy","year":"2009","unstructured":"Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis. 2009;204:334\u201341.","journal-title":"Atherosclerosis"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1161\/01.CIR.66.6.1176","volume":"66","author":"KG Berge","year":"1982","unstructured":"Berge KG, Canner PL, Hainline Jr A. High-density lipoprotein cholesterol and prognosis after myocardial infarction. Circulation. 1982;66:1176\u20138.","journal-title":"Circulation"},{"key":"3_CR15","first-page":"19","volume":"109","author":"HJ Kempen","year":"1987","unstructured":"Kempen HJ, van Gent CM, Buytenhek R, Buis B. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. J Lab Clin Med. 1987;109:19\u201326.","journal-title":"J Lab Clin Med"},{"issue":"Suppl 2","key":"3_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/BF00054748","volume":"5","author":"S Mochizuki","year":"1991","unstructured":"Mochizuki S, Okumura M, Tanaka F, Sato T, Kagami A, Tada N, et al. Ischemia-reperfusion arrhythmias and lipids: effect of human high- and low-density lipoproteins on reperfusion arrhythmias. Cardiovasc Drugs Ther. 1991;5 Suppl 2:269\u201376.","journal-title":"Cardiovasc Drugs Ther"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/01.RES.0000054201.60308.1A","volume":"92","author":"L Calabresi","year":"2003","unstructured":"Calabresi L, Rossoni G, Gomaraschi M, Sisto F, Berti F, Franceschini G. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res. 2003;92:330\u20137.","journal-title":"Circ Res"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/jpet.103.057141","volume":"308","author":"G Rossoni","year":"2004","unstructured":"Rossoni G, Gomaraschi M, Berti F, Sirtori CR, Franceschini G, Calabresi L. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia\/reperfusion injury. J Pharmacol Exp Ther. 2004;308:79\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.atherosclerosis.2007.08.028","volume":"197","author":"M Marchesi","year":"2008","unstructured":"Marchesi M, Booth EA, Rossoni G, Garcia RA, Hill KR, Sirtori CR, et al. Apolipoprotein A-IMilano\/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart. Atherosclerosis. 2008;197:572\u20138.","journal-title":"Atherosclerosis"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","volume":"114","author":"G Theilmeier","year":"2006","unstructured":"Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 2006;114:1403\u20139.","journal-title":"Circulation"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1440-1681.2010.05387.x","volume":"37","author":"KL Andrews","year":"2010","unstructured":"Andrews KL, Moore XL, Chin-Dusting JP. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium. Clin Exp Pharmacol Physiol. 2010;37:736\u201342.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/cvr\/cvp024","volume":"82","author":"MA Frias","year":"2009","unstructured":"Frias MA, James RW, Gerber-Wicht C, Lang U. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1\/2: role of sphingosine-1-phosphate. Cardiovasc Res. 2009;82:313\u201323.","journal-title":"Cardiovasc Res"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cvr\/cvp289","volume":"85","author":"MA Frias","year":"2010","unstructured":"Frias MA, Lang U, Gerber-Wicht C, James RW. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc Res. 2010;85:118\u201326.","journal-title":"Cardiovasc Res"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"H1022","DOI":"10.1152\/ajpheart.00902.2009","volume":"298","author":"R Tao","year":"2010","unstructured":"Tao R, Hoover HE, Honbo N, Kalinowski M, Alano CC, Karliner JS, et al. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. Am J Physiol Heart Circ Physiol. 2010;298:H1022\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92\u2013100.","journal-title":"J Clin Invest"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/eurheartj\/ehq484","volume":"32","author":"S Lecour","year":"2011","unstructured":"Lecour S, James RW. When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J. 2011;32:680\u20135.","journal-title":"Eur Heart J"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1194\/jlr.R039479","volume":"54","author":"C Mineo","year":"2013","unstructured":"Mineo C, Shaul PW. Regulation of signal transduction by HDL. J Lipid Res. 2013;54:2315\u201324.","journal-title":"J Lipid Res"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejphar.2008.02.089","volume":"585","author":"AE Alewijnse","year":"2008","unstructured":"Alewijnse AE, Peters SL. Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol. 2008;585:292\u2013302.","journal-title":"Eur J Pharmacol"},{"key":"3_CR29","doi-asserted-by":"publisher","first-page":"H1487","DOI":"10.1152\/ajpheart.01003.2010","volume":"301","author":"EE Egom","year":"2011","unstructured":"Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, et al. Activation of Pak1\/Akt\/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol Heart Circ Physiol. 2011;301:H1487\u201395.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1006\/jmcc.2002.1533","volume":"34","author":"S Lecour","year":"2002","unstructured":"Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol. 2002;34:509\u201318.","journal-title":"J Mol Cell Cardiol"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.02.003","volume":"228","author":"MA Frias","year":"2013","unstructured":"Frias MA, Pedretti S, Hacking D, Somers S, Lacerda L, Opie LH, et al. HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis. 2013;228:110\u20136.","journal-title":"Atherosclerosis"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.108.805242","volume":"118","author":"G Heusch","year":"2008","unstructured":"Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. 2008;118:1915\u20139.","journal-title":"Circulation"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.5483\/BMBRep.2009.42.7.393","volume":"42","author":"KH Cho","year":"2009","unstructured":"Cho KH. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 2009;42:393\u2013400.","journal-title":"BMB Rep"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290:2292\u2013300.","journal-title":"JAMA"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.108.182063","volume":"103","author":"JA Shaw","year":"2008","unstructured":"Shaw JA, Bobik A, Murphy A, Kanellakis P, Blombery P, Mukhamedova N, et al. Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res. 2008;103:1084\u201391.","journal-title":"Circ Res"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1161\/01.CIR.0000013424.28206.8F","volume":"105","author":"LE Spieker","year":"2002","unstructured":"Spieker LE, Sudano I, Hurlimann D, Lerch PG, Lang MG, Binggeli C, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation. 2002;105:1399\u2013402.","journal-title":"Circulation"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jacc.2008.12.008","volume":"53","author":"S Patel","year":"2009","unstructured":"Patel S, Drew BG, Nakhla S, Duffy SJ, Murphy AJ, Barter PJ, et al. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol. 2009;53:962\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1124\/jpet.104.070789","volume":"311","author":"M Marchesi","year":"2004","unstructured":"Marchesi M, Booth EA, Davis T, Bisgaier CL, Lucchesi BR. Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury. J Pharmacol Exp Ther. 2004;311:1023\u201331.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Advances in Experimental Medicine and Biology","Oxidative Stress and Inflammation in Non-communicable Diseases - Molecular Mechanisms and Perspectives in Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-07320-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T19:51:44Z","timestamp":1676404304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-07320-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319073194","9783319073200"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-07320-0_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"24 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}